PARD (Poniard Pharmaceuticals) Marketable Securities: $0.00 Mil (As of Sep. 2011)


What is Poniard Pharmaceuticals Marketable Securities?

Poniard Pharmaceuticals PARD Marketable Securities is $0.00 Mil as of Sep. 2011.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Poniard Pharmaceuticals's Marketable Securities for the quarter that ended in Sep. 2011 was $0.00 Mil.

Poniard Pharmaceuticals's annual Marketable Securities declined from Dec. 2008 ($28.61 Mil) to Dec. 2009 ($27.45 Mil) and declined from Dec. 2009 ($27.45 Mil) to Dec. 2010 ($3.05 Mil).

Poniard Pharmaceuticals  (OTCPK:PARD) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Poniard Pharmaceuticals Marketable Securities Related Terms

Poniard Pharmaceuticals Marketable Securities Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Marketable Securities Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.56 63.29 28.61 27.45 3.05

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.33 3.05 0.00 0.00 0.00

Poniard Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Poniard Pharmaceuticals (PARD) has a Marketable Securities of $0.00 Mil as of Sep. 2011. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Marketable Securities too high?
Poniard Pharmaceuticals' current Marketable Securities is $0.00 Mil.
How does Poniard Pharmaceuticals' Marketable Securities compare to OBMP and NSPX?
Poniard Pharmaceuticals' Marketable Securities of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Marketable Securities is $0.00 Mil as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.